Inventor
MICHAEL J. HUNTER
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07KPeptides31%
C12NMicroorganisms or enzymes6%
PatentTitleYear
12,134,636Immunoglobulins and uses thereof202411,767,354Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors202311,591,379Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors202311,401,315Immunoglobulins and uses thereof202211,208,464GDF15 fusion proteins and uses thereof2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021Patents assigned to JANSSEN BIOTECH INC (1)· patent assignee history
2021Patents assigned to JANSSEN SCIENCES IRELAND UNLIMITED CO (1)· patent assignee history
2021–2024Based in US· patent location history
2022–2024Patents assigned to JANSSEN PHARMACEUTICA NV (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| JANSSEN PHARMACEUTICA NV | 4 | 2022–2024 |
| JANSSEN BIOTECH INC | 1 | 2021 |
| JANSSEN SCIENCES IRELAND UNLIMITED CO | 1 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2021–2024 |